Today, Don’t Rush to Crush will have a new home on Therapeutic Guidelines platforms. This crushingly good digital resource will give health professionals access to a dedicated product app, enhanced user-centric design, and extensive upgrades.
Included in the Pharmacy Board of Australia’s list of essential references for pharmacy practice, the new Don't Rush to Crush web app includes information on more than 600 oral medicines available in Australia.
Trusted by clinicians for 15 years, Don’t Rush to Crush is researched, reviewed and consistently updated by multidisciplinary experts for Australian practice, and in recent years has expanded through Australia-first dispersion testing, Australia-first oral liquid thickness testing and in response to medicines shortages.
The new Don't Rush to Crush digital resource features extensive upgrades as well as many other enhancements.
Here’s what you can expect from your Don’t Rush to Crush subscription:
Brand new user interface across the web and mobile app
Dedicated product app with over 600+ medicines
New navigation for more intuitive access
Current advice via continuous updates
Modern dedicated mobile apps for Android and iOS
Content offline access
Also, users with individual subscriptions to Therapeutic Guidelines will now be able to seamlessly switch between all products if they have a valid subscription.
The launch of the dedicated Don’t Rush to Crush product follows last week’s app launch of ObesiD, an industry-first resource designed to enhance care for patients with obesity.
These two clinical resources are brought to you by Advanced Pharmacy Australia in partnership with Therapeutic Guidelines. Through this partnership, Therapeutic Guidelines and Advanced Pharmacy Australia reaffirm their commitment to creating reliable, independent and evidence-based Australian clinical resources, now and into the future. This partnership represents an exciting and innovative step forward in Australian health publishing.
